Ultragenyx
RARE
Ultragenyx (RARE) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wells Fargo | Maintained | Overweight | $50.00 from $46.00 | Aug 28, 2026 |
| JP Morgan | Maintained | Overweight | $80.00 from $75.00 | Aug 25, 2026 |
| Morgan Stanley | Maintained | Overweight | $74.00 from $67.00 | Aug 21, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $103.00 from $96.00 | Aug 20, 2026 |
| Wells Fargo | Maintained | Overweight | $46.00 from $45.00 | Aug 20, 2026 |
| Citigroup | Maintained | Buy | $58.00 from $45.00 | Aug 20, 2026 |
| Canaccord Genuity | Maintained | Buy | $83.00 from $81.00 | Aug 20, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $50.00 | Aug 10, 2026 |
| Wells Fargo | Maintained | Overweight | $45.00 from $47.00 | Aug 5, 2026 |
| Guggenheim | Maintained | Buy | $35.00 from $43.00 | Aug 4, 2026 |
| RBC Capital | Maintained | Outperform | $40.00 from $35.00 | Jul 7, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $96.00 from $84.00 | May 21, 2026 |
| Guggenheim | Maintained | Buy | $43.00 from $52.00 | May 8, 2026 |
| Wedbush | Maintained | Neutral | $26.00 from $27.00 | May 8, 2026 |
| Wedbush | Maintained | Neutral | $26.00 from $27.00 | May 6, 2026 |
| Wells Fargo | Maintained | Overweight | $47.00 from $45.00 | May 6, 2026 |
| Barclays | Maintained | Overweight | $43.00 from $44.00 | Apr 29, 2026 |
| Morgan Stanley | Maintained | Overweight | $67.00 from $50.00 | Apr 16, 2026 |
| Goldman Sachs | Downgraded | Buy → Neutral | $25.00 from $61.00 | Mar 24, 2026 |
| JP Morgan | Maintained | Overweight | $74.00 from $120.00 | Mar 12, 2026 |
Frequently asked questions
What is the latest analyst rating on RARE?
On Aug 28, 2026, Wells Fargo maintained Ultragenyx at Overweight with a price target of $50.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.